Hong Peng Wang
Sales & Marketing at PEIJIA MEDICAL LIMITED
Profile
Hong Peng Wang is currently the Marketing Director at Peijia Medical Technology (Suzhou) Co., Ltd.
and the Vice President-Marketing at Peijia Medical Ltd.
Prior to these roles, she held the position of Senior Manager-Marketing at Philips (China) Investment Co., Ltd.
from 2010 to 2018.
Before that, she worked as a Product Manager at Johnson & Johnson Medical (Shanghai) Ltd.
from 2007 to 2010.
Additionally, she served as a Marketing Manager at Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd.
from 2018 to 2019.
Ms. Wang completed her undergraduate degree at Shanghai Medical College of Fudan University in 2003 and obtained an MBA from Olin Business School in 2021.
Hong Peng Wang active positions
| Companies | Position | Start |
|---|---|---|
| PEIJIA MEDICAL LIMITED | Sales & Marketing | 01/07/2019 |
Peijia Medical Technology (Suzhou) Co. Ltd.
 Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Sales & Marketing | 01/07/2019 |
Former positions of Hong Peng Wang
| Companies | Position | End |
|---|---|---|
| Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. | Sales & Marketing | 01/06/2019 |
Philips (China) Investment Co., Ltd.
 Philips (China) Investment Co., Ltd. Electronics/AppliancesConsumer Durables Part of Koninklijke Philips NV, Philips (China) Investment Co., Ltd. is a Chinese company that manufactures consumer electronic products. The private company is based in Shanghai, China. The company was founded in 1990. Patrick S. Kung has been the CEO of the company since 2008. | Sales & Marketing | 01/12/2018 |
Johnson & Johnson Medical (Shanghai) Ltd.
 Johnson & Johnson Medical (Shanghai) Ltd. Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical (Shanghai) Ltd. wholesales baby and beauty products. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01/03/2010 |
Training of Hong Peng Wang
| Olin Business School | Masters Business Admin |
| Shanghai Medical College of Fudan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PEIJIA MEDICAL LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Philips (China) Investment Co., Ltd.
Philips (China) Investment Co., Ltd. Electronics/AppliancesConsumer Durables Part of Koninklijke Philips NV, Philips (China) Investment Co., Ltd. is a Chinese company that manufactures consumer electronic products. The private company is based in Shanghai, China. The company was founded in 1990. Patrick S. Kung has been the CEO of the company since 2008. | Consumer Durables |
Johnson & Johnson Medical (Shanghai) Ltd.
Johnson & Johnson Medical (Shanghai) Ltd. Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical (Shanghai) Ltd. wholesales baby and beauty products. The private company is based in Shanghai, China. | Distribution Services |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Health Technology |
| Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. |
- Stock Market
- Insiders
- Hong Peng Wang
